Alicia Borbalas-Lozano - Publications

Impact of clinical and dosimetric factors on severe oral mucositis in head and neck cancer: insights from a phase II clinical trial.

Journal: Frontiers in oncology

Published: August 04, 2025

Correction: Evidence and reality: an observational study on pharmacological outcomes in advanced head and neck tumors.

Journal: Frontiers in oncology

Published: August 01, 2025

Effect of a Probiotic Combination on Clinical and Microbiological Oral Parameters in Head and Neck Cancer Patients: A Randomised Clinical Trial.

Journal: Cancers

Published: June 11, 2025

Evidence and reality: an observational study on pharmacological outcomes in advanced head and neck tumors.

Journal: Frontiers in oncology

Published: March 22, 2025

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy.

Journal: Frontiers in oncology

Published: May 25, 2022

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 07, 2020

Update in pelvic and retroperitoneal sarcoma management: The role of compartment surgery.

Journal: Cirugia espanola

Published: March 28, 2019

Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.

Journal: Archives of medical research

Published: February 14, 2013